Since it is widely agreed that DNA-damage response is integral to the actions of p53 as a tumour suppressor, it is believed that VA can induce DNA damage in MCF-7 cells, which in turn activates p53 due to the release from Mdm2, and subsequently triggers various downstream effects. The gene discussed is TP53; the disease is neoplasm.